About this event
In this webinar, you will learn about key achievements within the Recomb project, recent progress in clinical trials for RAG1-SCID, and the impact of gene therapy on quality of life and cost-effectiveness for SCID patients. Join us to explore the future of gene therapy and its potential to transform patient care.
Hosted by
-
Team member
Ipopi OfficeT
The International Patient Organisation for Primary Immunodeficiencies (IPOPI) is an international not for profit organisation dedicated to improving awareness, access to early diagnosis and optimal treatments for primary immunodeficiency (PID) patients worldwide.
-
Team member
Johan PrevotJP T
-
Guest speaker
Arjan Lankester ProfessorG
-
Guest speaker
Maartje BlomMB G
-
Guest speaker
Frank StaalG
-
Team member
Ipopi Communications Communications Manager @ IPOPIT
-
Team member
Lucia MamedeLM T
IPOPI
Improving PID patients' lives. Worldwide.The International Patient Organisation for Primary Immunodeficiencies (IPOPI) is an international not for profit organisation dedicated to improving awareness, access to early diagnosis and optimal treatments for primary immunodeficiency (PID) patients worldwide.
